Lek Wins a Case against Pfizer's Patent Lawsuit
Ljubljana, 12 February - LEK/PFIZER/LAWSUIT
The Ljubljana court of first instance has recently ruled that Lek's production of generic drug amlodipin benzensulphonat did not violate Pfizer's patent rights.
The rest of this news item is available to subscribers.
The news item consists of 553 characters (without spaces) or 102 words words.
Buy the news item. Price: 2 tokens; on account: 0 tokens.